Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment with Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in Japan-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment with Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in Japan

Published:2022-03 Issue: Volume:28 Page:105-111
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Hirose Tomohiro,Kawaguchi Isao,Murata Tatsunori,Atsumi Tatsuya

Funder

Pfizer Japan Inc

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference47 articles.

1. The pathogenesis of rheumatoid arthritis;McInnes;N Engl J Med,2011

2. Socio-economic consequences of rheumatoid arthritis in the first years of the disease;Albers;Rheumatol (Oxford),1999

3. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I);Yamanaka;Mod Rheumatol,2014

4. Epidemiology of adult rheumatoid arthritis;Alamanos;Autoimmun Rev,2005

5. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care;Curtis;Clin Ther,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of tumor necrosis factor-alpha inhibitors: a systematic review and meta-analysis of cost-utility studies;Expert Review of Pharmacoeconomics & Outcomes Research;2023-08-28

2. Rheumatoid arthritis: advances in treatment strategies;Molecular and Cellular Biochemistry;2022-06-21